Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002

Tissue Antigens

Volumn 62, Issue 1, 2003, Pages 79-86

  Marsh, Steven G E ^a,b   Parham, P ^a,f   Dupont, B ^a,c   Geraghty, D E ^a,d   Trowsdale, J ^a,g   Middleton, D ^a,e   Vilches, C ^a,j   Carrington, M ^a,h   Witt, C ^a,l   Guethlein, L A ^a,f   Shilling, H ^a,i   Garcia, C A ^a,b   Hsu, K C ^a,c   Wain, H ^a,k  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b ANTHONY NOLAN RESEARCH INSTITUTE   (United Kingdom)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d USA   (United States)

^e N Ireland Tissue Typing Laboratory   (United Kingdom)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h NATIONAL CANCER INSTITUTE   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^k UNIVERSITY COLLEGE LONDON   (United Kingdom)

^l ROYAL PERTH HOSPITAL   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN RECEPTOR;

CHROMOSOME 19; GENETIC POLYMORPHISM; HLA SYSTEM; HUMAN; KILLER CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE SUBPOPULATION; UNINDEXED SEQUENCE;

CHROMOSOMES, HUMAN, PAIR 19; DATABASES, NUCLEIC ACID; DATABASES, PROTEIN; GENOTYPE; HAPLOTYPES; HUMANS; KILLER CELLS; POLYMORPHISM, GENETIC; RECEPTORS, IMMUNOLOGIC; TERMINOLOGY; WORLD HEALTH ORGANIZATION;

EID: 12444315081     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2003.00072.x     Document Type: Review

References (36)

1. Marsh SGE, Albert ED, Bodmer WF et al. Nomenclature for factors of the HLA system, 2002. Tissue Antigens 2002: 60: 407-64.
2. Long EO, Colonna M, Lanier LL. Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature. Immunol Today 1996: 17: 100.
3. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002: 20: 217-51.
4. Gomez-Lozano N, Gardiner CM, Parham P, Vilches C. Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. Immunogenetics 2002: 54: 314-9.
5. Moretta A, Bottino C, Biassoni R. CD158a (p58.1/p50.1) and CD1586 (p58.2/p50.2) natural killer receptors for HLA-C alleles: Workshop Panel Report. In: Kishimoto H, Kikutani A, von dem Born, et al. (eds) Leucocyte Typing VI: White Cell Differentiation Antigens. New York: Garland Publishing Inc., 1997: 1109-220.
6. André P, Biassoni R, Colorma M et al. New nomenclature for MHC receptors. Nature Immunol 2001: 2: 661.
7. Pascal V, Vivier E, André P. CD158 (killer immunoglobulin-tike receptors family) report. In: Mason D (ed). Leucocyte Typing VII. New York, Oxford: University Press, 2002: 412-3.
8. Uhrberg M, Valiante NM, Shum BP et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997: 7: 753-63.
9. Hsu KC, Chida S, Geraghty DE, Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev 2002: 190: 40-52.
10. Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995: 268: 405-8.
11. Wagtmann N, Biassoni R, Cantoni C et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin- related molecules with diversity in both the extra- and intracellular domains. Immunity 1995: 2: 439-49.
12. Selvakumar A, Steffens U, Dupont B. NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains. Tissue Antigens 1996: 48: 285-94.
13. Vilches C, Rajalingam R, Uhrberg M, Gardiner CM, Young NT, Parham P. KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig- like domains. J Immunol 2000: 164: 5797-804.
14. Biassoni R, Cantoni C, Falco M et al. The human leukocyte antigen (HLA)-C-specific 'activatory' or 'inhibitory' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 1996: 183: 645-50.
15. Dohring C, Samaridis J, Colonna M. Alternatively spliced forms of human killer inhibitory receptors. Immunogenetics 1996: 44: 227-30.
16. Torkar M, Norgate Z, Colonna M, Trowsdale J, Wilson MJ. Isotypic variation of novel immunoglobulin-like transcript/killer cell inhibitory receptor loci in the leucocyte receptor complex. Eur J Immunol 1998: 28: 3959-67.
17. Rajalingam R, Gardiner CM, Canavez F, Vilches C, Parham P. Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors. Tissue Antigens 2001: 57: 22-31.
18. Valiante NM, Uhrberg M, Shilling HG et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997: 7: 739-51.
19. Selvakumar A, Steffens U, Dupont B. Polymorphism and domain variability of human killer cell inhibitory receptors. Immunol Rev 1997: 155: 183-96.
20. Cantoni C, Verdiani S, Falco M et al. p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur J Immunol 1998: 28: 1980-90.
21. Selvakmnar A, Steffens U, Palanisamy N, Chaganti RS, Dupont B. Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR103. Tissue Antigens 1997: 49: 564-73.
22. Vilches C, Gardiner CM, Parham P. Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene. J Immunol 2000: 165: 6416-21.
23. Wilson MJ, Torkar M, Haude A et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci U S A 2000: 97: 4778-83.
24. Biassoni R, Pessino A, Malaspina A et al. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur J Immunol 1997: 27: 3095-9.
25. Bottino C, Sivori S, Vitale M et al. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur J Immunol 1996: 26: 1816-24.
26. Maxwell LD, Wallace A, Middleton D, Curran MD. A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey. Tissue Antigens 2002: 60: 254-8.
27. Hsu KC, Liu X-R, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 2002: 169: 5118-29.
28. Vilches C, Pando MJ, Rajalingam R, Gardiner CM, parham P. Discovery of two novel variants of KIR2DS5 reveals this gene to be a common component of human KIR 'B' haplotypes. Tissue Antigens 2000: 56: 453-6.
29. Martin AM, Freitas EM, Witt CS, Christiansen FT. The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster. Immunogenetics 2000: 51: 268-80.
30. Wagtmann N, Rajagopalan S, Winter CC, Peruzzi M, Long EO. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 1995: 3: 801-9.
31. Pende D, Biassoni R, Cantoni C et al. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med 1996: 184: 505-18.
32. Gardiner CM, Guethlein LA, Shilling HG et al. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol 2001: 166: 2992-3001.
33. D'Andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. J Immunol 1995: 155: 2306-10.
34. Crum KA, Logue SE, Curran MD, Middleton D. Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires. Tissue Antigens 2000: 56: 313-26.
35. Shilling HG, Guethlein LA, Cheng NW et al. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol 2002: 168: 2307-15.
36. Long EO, Barber DF, Burshtyn DN et al. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158). Immunol Rev 2001: 181: 223-33.